Cell and Gene Outsourcing
-
Nu-Tek Soy Peptone HSP-A10KF
2/13/2026
An ultra-filtered, enzymatically hydrolyzed soy-based ingredient offering high solubility, low bioburden, and low endotoxin levels for advanced fermentation and cell culture media applications.
-
The Adenovirus Revolution In Cancer Treatment
2/13/2026
Adenoviruses are being reimagined as powerful tools for oncolytic cancer therapy, using their immunogenicity, tumor selectivity, and synergy with immunotherapy to drive new clinical progress.
-
Advancing Sustainable, Animal‑Free Cell Nutrition
2/13/2026
See a shift toward animal‑free bioproduction, emphasizing plant‑based cell nutrients, sustainable manufacturing, supply‑chain security, and expert‑driven collaboration to support future therapeutic breakthroughs.
-
Collaborative Variability Reduction In Cell Culture Media
2/13/2026
Variability reduction programs improve biomanufacturing by controlling raw‑material complexity, optimizing critical attributes, and boosting productivity through data‑driven partnerships.
-
Variability Reduction Program (VRP)
2/13/2026
The Variability Reduction Program delivers customized, animal‑free media components that cut variability, boost productivity, and ensure scalable, reliable supply.
-
Industrial Fermentation
2/13/2026
Animal‑free, high‑quality peptones, hydrolysates, and yeast extracts for industrial fermentation, delivering scalable, soluble, reliable media without supply delays.
-
Using Plant Peptones To Boost Plasmid Yield And Induction
2/12/2026
Uncover how Nu‑Tek’s plant-based peptones support E. coli growth, plasmid yield, and controlled induction, offering a sustainable, animal-free alternative for biopharmaceutical cell culture.
-
Nu-Tek Products Plasmid Production And Fold Induction In E. Coli EPI300
2/12/2026
See plant-based peptones used for plasmid production in E. coli, demonstrating strong growth performance, consistent plasmid yields, and reduced contamination risk for biopharmaceutical manufacturing.
-
Viral Vector Development And Manufacturing Services
2/12/2026
Supported by a global site network, supply chain infrastructure, and deep technical and regulatory expertise, we provide a coordinated approach to accelerate your therapy’s journey.
-
From Promise To Patients: Smarter Pathways To Scale In Cell And Gene Therapy Manufacturing
2/12/2026
As the field evolves, the strategies developers choose may prove just as influential as the therapies themselves in determining how quickly innovation reaches patients.